|
시장보고서
상품코드
1463770
세계의 삽관 튜브 시장 : 시장 규모, 점유율 분석(제품별, 삽입 경로별, 용도별, 최종사용자별) - 산업 수요 예측(-2030년)Intubation Tubes Market Size and Share Analysis by Product, Route, Route, End User - Global Industry Demand Forecast to 2030 |
||||||
주요 하이라이트
삽관 튜브 시장은 2023년에 27억 2,760만 달러 규모에 달하며, 6.5% 이상의 CAGR로 성장하며, 2030년에는 42억 9,440만 달러로 확대합니다.
교통사고와 외상의 증가가 업계의 주요 촉진요인입니다. 교통사고에 의한 사망자수는 해마다 대폭 증가하고 있습니다.
SARS-CoV-2의 발생은 업계의 매출을 비약적으로 증가시켰습니다. 코로나바이러스의 발생은 이 업계에 큰 호영향을 미쳤습니다.
주요 인사이트
일반 카테고리는 2023년에 업계 최대인 40%를 차지했습니다. 이것은 호흡기질환의 발생률이 급상승하고 있으므로 외과적 시술의 수량이 증가하고 있는 것에 기인하고 있습니다.
강화 카테고리는 향후 수년간 높은 연평균 성장률로 추진합니다. 이것은 수술을 필요로 하는 신경질환을 앓고 있는 환자 수의 증가, 안면 수술 및 교통사고 건수의 증가에 의한 것입니다.
기관절개 카테고리는 2023년에 약 75%의 점유율을 차지하며 업계에 대한 최대 기여자였습니다. 기관삽관은 환자에게 쾌적하기 때문에 이 튜브의 가장 일반적인 삽입 루트입니다.
2023년에는 응급 치료가 약 55%로 최대 점유율을 차지했습니다. 이것은 심폐정지, 사고, 호흡 곤란, 기도 폐색 등 긴급사태의 발생률이 증가하고 있는 것에 기인하고 있습니다.
북미는 2023년에는 약 60%의 점유율을 차지하며 업계에 대한 최대 기여자였습니다.
북미의 성장은 강고한 헬스케어 서비스와 인프라, 확립된 상환 정책, 의료 업계에 의한 기술적으로 개량된 디바이스 수용의 증가에 의한 것입니다.
APAC는 이 10년간 가장 빠른 CAGR로 성장할 전망입니다. 이것은 호흡기 질환의 원인이 되는 오염 레벨의 증가, 고령자 인구의 급증, 심폐 질환의 대폭적인 발생률, 이 모든 것이 최종적으로 수술의 필요성 증대를 초래하기 때문입니다.
세계의 삽관 튜브 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가의 시장 규모 동향 전망(금액 기반, 2017-2030년), 제품별·삽입 경로별·용도별·최종사용자별 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 삽입 경로별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 삽입 경로별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 삽입 경로별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 제품/서비스 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Teleflex Incorporated
- Medtronic plc
- Medline Industries LP
- Venner Medical International
- Armstrong Medical Inc.
- ICU Medical Inc.
- Convatec Limited
제31장 부록
KSA 24.04.30Key Highlights
The intubation tubes market generated a value of USD 2,727.6 million in 2023, and it will increase to USD 4,294.4 million, with more than 6.5% CAGR, by 2030.
The increasing prevalence of road accidents and trauma is a key industry driver. There has been a substantial increase in the count of road accidents resulting in death over the years.
As per the WHO, around 1.5 million people die in road accidents annually.
A substantial emotional trauma to victims' families and economic loss are the extra burdens that come along with such accidents.
Major accidents led to substantial trauma to patients, who then necessitated surgical intervention or immediate treatment, thus boosting the requirement for intubation tubes.
The outbreak of SARS-CoV-2 resulted in exponential growth in industry revenue. The outbreak of coronavirus had a substantial positive impact on this industry.
There was a quick increase in the count of seriously ill patients, for whom intubation was essential in emergencies because one of the main problems that came along with the ailment was difficulty in breathing.
Intubation tubes are an accepted means of delivering breathing support to patients with novel coronavirus.
Key Insights
The regular category accounted for the largest share of the industry in 2023, of 40%. This can be attributed to the increasing volume of surgical measures because of the surging incidence of respiratory diseases.
The reinforced category will propel at a high compound annual growth rate in the years to come. This will be because of the increasing count of patients suffering from neurological conditions needing surgeries and the rising count of facial surgeries and road accidents.
The orotracheal category was the largest contributor to the industry in 2023, with approximately 75% share. Orotracheal is the most common insertion route of these tubes because of its comfort for patients.
Orotracheal is extensively accepted in treating apneic and severely ill patients ailing from multisystem diseases and severe injuries.
Emergency treatment accounted for the largest share in 2023, of approximately 55%. This can be attributed to the increasing incidence of emergencies like cardiopulmonary arrest, accidents, respiratory distress, and obstruction of the airways.
Therapy will propel at a significant CAGR in the years to come. This will be mainly because of the surging count of surgical measures, most of which necessitate intubation tubes for managing the airways.
North America was the largest contributor to the industry in 2023, with a share of approximately 60%.
The growth in North America is due to the robust healthcare services and infrastructure; well-established reimbursement policies, and rising acceptance of technologically improved devices by the medical industry.
APAC is likely to propel at the fastest compound annual growth rate during this decade. This is because of the increasing level of pollution leading to respiratory conditions, surging elderly populace, and substantial incidence of cardiopulmonary illnesses, all of which eventually result in the growing requirement for surgeries.
The intubation tubes industry is very fragmented as well as competitive. Players in this market are continuously involved in strategic initiatives like new product launches, acquisitions, collaborations, and technological improvements, to enhance their presence.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by route
- 1.4.3. Market size breakdown, by application
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Route (2017-2030)
- 6.4. Market Revenue, by Application (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Route (2017-2030)
- 7.4. Market Revenue, by Application (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Route (2017-2030)
- 8.4. Market Revenue, by Application (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Route (2017-2030)
- 9.4. Market Revenue, by Application (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Route (2017-2030)
- 10.4. Market Revenue, by Application (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Route (2017-2030)
- 11.4. Market Revenue, by Application (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Route (2017-2030)
- 12.4. Market Revenue, by Application (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Route (2017-2030)
- 13.4. Market Revenue, by Application (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Route (2017-2030)
- 14.4. Market Revenue, by Application (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Route (2017-2030)
- 15.4. Market Revenue, by Application (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Route (2017-2030)
- 16.4. Market Revenue, by Application (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Route (2017-2030)
- 17.4. Market Revenue, by Application (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Route (2017-2030)
- 18.4. Market Revenue, by Application (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Route (2017-2030)
- 19.4. Market Revenue, by Application (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Route (2017-2030)
- 20.4. Market Revenue, by Application (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Route (2017-2030)
- 21.4. Market Revenue, by Application (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Route (2017-2030)
- 22.4. Market Revenue, by Application (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Route (2017-2030)
- 23.4. Market Revenue, by Application (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Route (2017-2030)
- 24.4. Market Revenue, by Application (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Route (2017-2030)
- 25.4. Market Revenue, by Application (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Route (2017-2030)
- 26.4. Market Revenue, by Application (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Route (2017-2030)
- 27.4. Market Revenue, by Application (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Route (2017-2030)
- 28.4. Market Revenue, by Application (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Teleflex Incorporated
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Medtronic plc
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Medline Industries LP
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Venner Medical International
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Armstrong Medical Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. ICU Medical Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Convatec Limited
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
